1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Trafalgar International Inc.

Trafalgar International Inc.

OOTC:TRFA
1.09
USD
-0.05
(-4.39%)
Trafalgar International Inc.
OTC:TRFA
(OTC Markets)

Recent

price

1.09

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Trafalgar International, Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. It focuses on the development and commercialization of innovative cannabinoid therapeutics. The company was founded on March 14, 2014 and is headquartered in Miami, FL.